Intravitreal dexamethasone implant (Ozurdex) in coats' disease

Creative Commons License

SAATCİ A. O., Doruk H. C., YAMAN A.

Case Reports in Ophthalmology, vol.4, no.3, pp.122-128, 2013 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 4 Issue: 3
  • Publication Date: 2013
  • Doi Number: 10.1159/000355363
  • Journal Name: Case Reports in Ophthalmology
  • Journal Indexes: Scopus
  • Page Numbers: pp.122-128
  • Keywords: Coats' disease, Dexamethasone implant, Laser photocoagulation, Ranibizumab
  • Dokuz Eylül University Affiliated: Yes


We injected an intravitreal dexamethasone implant in two eyes of 2 pediatric patients with Coats' disease in addition to other treatment modalities, such as intravitreal ranibizumab injection and indirect laser photocoagulation. In both eyes, intraocular pressure moderately rose in a temporary fashion. The dexamethasone implant seems to be a valuable addition to the armamentarium of treatment options for Coats' disease as it necessitates fewer injections than anti-VEGF injections and thereby fewer sessions of general anesthesia in the pediatric population. © 2013 S. Karger AG, Basel.